This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Innovations in Tumor Monitoring by Leslie C Hall
Introduction
Leslie C Hall is an innovative inventor based in Raleigh, NC (US). He has made significant contributions to the field of medical technology, particularly in the monitoring of tumors. His work focuses on developing methods and systems that enhance the evaluation and treatment of tumors through dynamic monitoring.
Latest Patents
Leslie C Hall holds a patent for "Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors." This patent describes methods for monitoring and evaluating the status of a tumor undergoing treatment. The process includes monitoring in vivo at least one physiological parameter associated with a tumor, transmitting data from an in situ located sensor to an external receiver, and analyzing the transmitted data. The method allows for dynamic tracking of monitored parameters over time and can identify favorable and unfavorable conditions for treatment. It also verifies the actual dosage of drugs or radiation received by the tumor. The system includes biocompatible sensors and telemetry-based operations, enabling remote monitoring even during non-active treatment periods.
Career Highlights
Leslie C Hall has dedicated his career to advancing medical technology. His innovative approach to tumor monitoring has the potential to significantly improve patient outcomes. With a focus on real-time data transmission and analysis, his work stands at the forefront of medical research.
Collaborations
Leslie has collaborated with notable professionals in his field, including Chang-Soo Kim and H Troy Nagle. These collaborations have further enriched his research and development efforts.
Conclusion
Leslie C Hall's contributions to tumor monitoring represent a significant advancement in medical technology. His innovative methods and systems are poised to enhance the treatment and evaluation of tumors, ultimately benefiting patients undergoing cancer treatment.